Johnston, Karen C <br/><br/>
Risk adjustment effect on stroke clinical trials.  [electronic resource] 

 -  Stroke  Feb 2004 
 - e43-5 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1524-4628 
<br/><br/><label>Standard No.: </label>10.1161/01.STR.0000109768.98392.4D  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Fibrinolytic Agents--therapeutic use<br/>Glasgow Outcome Scale<br/>Humans<br/>Models, Statistical<br/>Odds Ratio<br/>Prognosis<br/>Randomized Controlled Trials as Topic--statistics & numerical data<br/>Regression Analysis<br/>Risk Assessment<br/>Sample Size<br/>Severity of Illness Index<br/>Stroke--diagnosis<br/>Tissue Plasminogen Activator--therapeutic use<br/>Treatment Outcome<br/>United States